PMDA To Host Symposium On Drug Development In East Asia
This article was originally published in PharmAsia News
Executive Summary
Japan's Pharmaceuticals and Medical Device Agency will host a symposium Jan. 23 on the current climate and future forecast for drug development in East Asia at Kyushu University's Medical School in Fukuoka. PMDA President Tatsuya Kondo will give a keynote speech on PMDA's role and future plans, the agency's clinical review specialists will present international joint trials and post market safety inspections. Jae-Gook Shin of South Korea's Busan Paik Hospital will introduce recent developments of academia-based clinic trial infrastructure. (Click here for more - Japanese language
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.